Journey Medical Corp
DERM · XNASCIK 1867066fmd_119NZ685ZMS11ZCT5A9WGTR115Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2020 to Sep 30, 2026, 25 periods
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Total revenues | 45 | 63 | 74 | 79 | 56 | 62 |
| Cost of revenue | 15 | 32 | 31 | 23 | 21 | 21 |
| Gross profit | 30 | 31 | 43 | 56 | 35 | 41 |
| Research and development | – | 3 | 11 | 8 | 10 | 0 |
| Selling, general and administrative | 22 | 40 | 59 | 44 | 40 | 44 |
| Operating income | 8 | (35) | (28) | (2) | (14) | (8) |
| Interest expense | 1 | 7 | 2 | 2 | 3 | 4 |
| Other non-operating income (expense) | (1) | (7) | (2) | (2) | (1) | (3) |
| Income before taxes | 7 | (42) | (30) | (4) | (15) | (11) |
| Income tax expense | 2 | 2 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | 5 | (44) | (30) | (4) | (15) | (11) |
| Net income | 5 | (44) | (30) | (4) | (15) | (11) |